A

Arcus Biosciences

484 employees

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Basic info

Industry

biotechnology research

Sectors

Medicinal Chemistry
Biotechnology
Health Care
Protein Therapeutics
Therapeutics
Medical
Large Molecule Drug Discovery
Pharmaceutical
Biopharma
Immuno-oncology
Clinical Trials

Date founded

2015

Funding rounds raised

Total raised

$220M

from 16 investors over 16 rounds

A

Arcus Biosciences raised $220M on February 1, 2021

Investors: Gilead Sciences

A

Arcus Biosciences raised $200M on May 28, 2020

Investors: Gilead Sciences

A

Arcus Biosciences raised $107M on November 13, 2017

Investors: Leerink Partners LLC, Research Division, The Column Group, GV, The Invus Group, Hillhouse Capital Management, Wellington Management and Foresite Capital

A

Arcus Biosciences raised $70M on September 1, 2016

Investors: GV, Foresite Capital, The Invus Group, The Column Group and Celgene

A

Arcus Biosciences raised $50M on May 1, 2015

Investors: Celgene and The Column Group

FAQ